Monkeypox patients and their clinicians in the US now have more options to access treatments as the NIH opened up a late-stage clinical trial Friday to evaluate
Doctors already are using Tpoxx to treat monkeypox. The US has shipped 37,000 treatment courses of the antiviral as of Sept. 2 from the Strategic National Stockpile. But there isn’t any data to establish the safety and effectiveness of using Tpoxx to treat monkeypox in humans; the Food and Drug Administration approved TPOXX in 2018 for smallpox, a close cousin of monkeypox, based on animal data. ...